888-500-0370 mbcn@mbcn.org

MBCN News

This is a single blog caption

MBCN and RAN Clinical Trial Overview PLUS Two New TNBC Trials on Jan. 28, 2020

WHAT: Clinical Trial Overview PLUS Two New TNBC Trials
WHEN: Tuesday, January 28, 2020; 2 to 3 PM CST
REGISTER:
https://researchadvnetwork.formstack.com/…/2020_01_28mbcn_r…

MBCN, in collaboration with the Research Advocacy Network, is holding a webinar on Tuesday, January 28.

This is a great opportunity for patients and their caregivers to learn more about clinical trials in general as well as two clinical trials for people with metastatic triple negative breast cancer.

Both trials are for those with the TNBC subtype with specific biomarkers.

One trial is currently open and one is forthcoming. The trials will be presented by two outstanding clinicians, Dr. Matthew Goetz, Professor of Oncology and Pharmacology at the Mayo Clinic and Dr. Rita Nanda, Associate Professor of Medicine and Director of the Breast Cancer Oncology Program at the University of Chicago.

Our speakers are happy to answer your questions. Please join us!